Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 50 crore. The tenure of the instrument is 61 days and allotted on January 5, 2017.
The coupon/interest will be paid upfront at the rate of 6.79% per annum on maturity i.e. March 7, 2017. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 100 crore.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
